Cargando…
Topical Treatment of Human Skin and Cultured Keratinocytes with High-Dose Spironolactone Reduces XPB Expression and Induces Toxicity
Spironolactone (SP) is used to treat a variety of disparate disease states ranging from heart failure to acne through antagonism of the mineralocorticoid and androgen receptors. Although normally taken as an oral medication, recent studies have explored the topical application of SP onto the skin. H...
Autores principales: | Carpenter, M. Alexandra, Kemp, Michael G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659383/ https://www.ncbi.nlm.nih.gov/pubmed/34909723 http://dx.doi.org/10.1016/j.xjidi.2021.100023 |
Ejemplares similares
-
Spironolactone and XPB: An Old Drug with a New Molecular Target
por: Gabbard, Ryan D., et al.
Publicado: (2020) -
Spironolactone-induced XPB degradation requires TFIIH integrity and ubiquitin-selective segregase VCP/p97
por: Chauhan, Anil K., et al.
Publicado: (2020) -
Stimulation of the XPB ATP-dependent helicase by the beta subunit of TFIIE
por: Lin, Yin C., et al.
Publicado: (2005) -
G-quadruplexes are genomewide targets of transcriptional helicases XPB and XPD
por: Gray, Lucas T., et al.
Publicado: (2014) -
The TFIIH Subunit p89 (XPB) Localizes to the Centrosome during Mitosis
por: Weber, Achim, et al.
Publicado: (2010)